Scope
The National Cancer Grid palliative-care delirium pathway combines recognition of acute fluctuating change, correction of contributing factors, symptom relief and family-supported care. This focused summary covers assessment, medication cautions and supportive care. Complete drug-titration pathways and the separate palliative-sedation protocol are outside its scope.
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Recognise acute change and assess contributing illness
- Suspect delirium in a cancer patient with acute fluctuating cognition, inattention, disorganised thought or speech, altered consciousness or perception, or disorientation. Both agitation and unusual quietness are described; a quiet presentation should not be overlooked. [1]
- Use structured delirium assessment rather than observation alone. The pathway names CAM or the 4AT, with RASS for arousal assessment, and notes that formal diagnostic confirmation should not delay symptom control. [1]
- Monitor and optimise coexisting illness, including hypertension, diabetes and asthma, while addressing the delirium episode. [1]
- Review medications for a drug-induced contribution and discontinue or modify implicated treatment as appropriate. The source lists anticholinergics, selected opioids and sedatives, corticosteroids and other centrally acting agents among possible contributors. [1]
- Identify and correct reversible contributors: dehydration, uncontrolled pain or other symptoms, sepsis, bowel or bladder dysfunction, electrolyte and metabolic disturbances, hypoxia or hypercarbia, hypoglycaemia, hypothyroidism and medication effects. Refer to internal medicine as appropriate. [1]
- New focal neurological signs, reduced consciousness, suspected brain metastases, falls or head injury, and anticoagulation use trigger consideration of CT or MRI and/or radiotherapy, neurology or neurosurgery referral. The palliative pathway qualifies imaging according to prognostic context. [1]
Keep symptom treatment and sedation decisions explicit
- The drug table specifically advises avoiding haloperidol in patients with dementia or parkinsonism. Do not treat its inclusion in the general delirium pathway as unrestricted suitability for those patients. [1]
- For terminal delirium with severe agitation, palliative sedation may be needed only through a shared decision after empathetic communication and documented informed consent. The source directs clinicians to the separate NCG palliative-sedation guidance. [1]
Support the family and communicate simply
- Respond to family distress and explain the connection between delirium, the illness and physiological disturbance. Help relatives understand their role in nonpharmacological care and support the burden of decisions. [1]
- Maintain a calm, patient and nonargumentative manner. Ask what helps the patient feel connected, including familiar surroundings and normal routines, and support effective communication among family members. [1]
- Use short, simple sentences and check understanding; repeat information if needed. Remind the person what is happening and how they are doing, while listening and offering reassurance. [1]
- Help the person orient to time and place with a visible clock or calendar. Familiar objects from home can help when the patient is in hospital. [1]
Attend to comfort, sensory aids and familiar support
- Make sure glasses and hearing aids are available, and offer assistance with food and drink. These are practical caregiver actions included alongside medical treatment. [1]
- Try to have a familiar person present, particularly in the evening when confusion may worsen. Keep a light available at night so the patient can orient if they wake. [1]
- Provide a stable, quiet and well-lit environment. The supportive-care section also encourages reorientation and attention to a normal sleep–wake pattern. [1]
Continue assessment and explain the episode after recovery
- Regular nursing review should cover delirium, pain, fever, feeding, bowel movements and fluid input and output. Follow the linked constipation and pressure-care guidance when those needs are present. [1]
- After recovery, offer an opportunity to discuss what happened and why. The patient may retain frightening emotions from the episode; an explanation from a familiar person or clinician may help them make sense of it. [1]
Limitations and use
- The source was released in May 2021. This summary excludes exact drug doses, infusion regimens and detailed antipsychotic-selection pathways.
- This is focused assessment and supportive-care coverage, not a complete investigation algorithm or treatment protocol for all causes of delirium.
- Palliative sedation requires the separately referenced NCG end-of-life guidance; its full eligibility, monitoring and consent process is not reproduced here.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- Approach to managing Delirium in a cancer patient
Selected recommendation material consulted
Publication details
- Issuing organisation
- NCG
- Resource type
- Clinical guideline · House clinical summary
- Source setting
- India
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.